The Cancer Letter

Inside information on cancer research and drug development

Vol.
25
No.
12
December 27, 2002Dec 27, 2002
Free
DOWNLOAD THE PDF

Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

Arimidex Continues To Show Improvement Over Tamoxifen

Iressa May Benefit Some Breast Cancer, Studies Find

Gleevec Improves Survival Of CML In Accelerated Phase

Phase II Study Tests Chemo Plus Mylotarg For AML

“Proof Of Concept” Shown In Early Trial Of PKC-412

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

Clinical Trials Approved By NCI During November Are Listed

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account